arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

OneMedNet Corp

ONMD

$4.44 ▼ -0.13 (-2.84%) at close

6 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Moderately Bullish

auto_awesome

Analytical Summary

OneMedNet Corp shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $197.8M

Dividend Yield —

Revenue Growth 111.4% ↗

Op. Margin —

ROIC 352.3% ↗

FCF / Share $-0.17 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -0.07

info Valuation on last close. End-of-day price, Nov 5, 2026.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.36M

↑ +111.4% —

Net Income Profit after all expenses

$-2.80M

↑ +72.3% —

FCF / Share Free cash flow per share

$-0.17

↑ +32.7% —

Long-Term Debt Long-term obligations

$220.00K

↓ -90.5% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability

Returns

Financial Health ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Feb 7, 2021 10-K ↗
Revenue Growth YoY (%)	111.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2127%)	-37.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-840%)	-11.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-329%)	—	—	—
EPS Growth YoY (%)	83.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	92.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	72.3% Excellent ↑ Excellent Improving Year-over-year change in net income	70.0% Excellent Excellent Year-over-year change in net income	-442.2% Weak Weak Year-over-year change in net income	N/M	—	—
FCF Growth YoY (%)	32.7% Excellent Excellent Year-over-year change in free cash flow	62.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—
Revenue CAGR 3Y (%)	5.6% Fair Fair Compound annual revenue growth over 3 years	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Feb 7, 2021 10-K ↗
Effective Tax Rate (%) (%)	-0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
Profit Margin (%) (%)	-206.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2676%)	—	—	—	—	—
FCF Margin (%) (%)	—	—	-473.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	2.68x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.14x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-13.99x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.07x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Feb 7, 2021 10-K ↗
Return on Invested Capital (%)	352.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	70.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	52.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-97.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	5.4% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-449.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-257.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1476.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-0.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	94.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+530%)	63.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+323%)	251.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1575%)	-67.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-548%)	-59.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-498%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Feb 7, 2021 10-K ↗
Debt to Equity (x)	-0.07x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-111%)	-0.29x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-142%)	-0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-110%)	—	—	—
Interest Coverage (x)	-420.30x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-369.42x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-28.33x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-365.00K	$4.47M	$883.00K	$-301.73K	$-453.15K	—
Debt / EBITDA (x)	-0.02x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.49x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.14x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Feb 7, 2021 10-K ↗
Revenue per Share (USD)	$0.03	$0.02	$0.14	—	—	—
Basic EPS, GAAP (USD)	$-0.06	$-0.36	$-4.65	—	—	—
Free Cash Flow per Share (USD)	$-0.17	$-0.25	$-0.66	—	—	—
Book Value per Share (USD)	$-0.06	$-0.57	$-0.57	$2.04	—	—
Tangible Book Value per Share (USD)	$-0.06	$-0.57	$-0.57	$2.04	—	—
Basic Weighted Avg Shares (shares)	44.55M	28.08M	7.27M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Feb 7, 2021 10-K ↗
Working Capital (USD)	$-2.73M	$-15.61M	$-13.47M	$18.57M	$246.23K	—
LT Debt (USD)	$220.00K	$2.32M	$465.00K	—	—	—
Total Equity (USD)	$-2.96M	$-15.95M	$-13.44M	$9.27M	$-8.61M	$0.00

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Feb 7, 2021 10-K ↗
Sales/Revenue/Turnover (USD)	$1.36M	$643.00K	$1.02M	$1.15M	—	—
Depreciation Expense (USD)	$65.00K	$57.00K	$28.00K	$24.81K	—	—
Net Income, GAAP (USD)	$-2.80M	$-10.13M	$-33.78M	$-6.23M	$5.14M	—
Operating Cash Flow (USD)	$-7.50M	$-6.98M	$-4.79M	$87.24M	$-378.49K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 6 years · 23 quarters

OneMedNet Corp

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ONMD with peers